6-K ·Filed Aug 12, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001654954-26-007504
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine PDMR share vesting and tax-cover sale with no trading signal. The insider retained the majority of vested shares (14,039 of 23,202), which is neutral. Monitor next quarterly earnings for operational updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
SNN ▼ -7.44% at T+20d
NEUTRAL call ✗ call lost -7.44% · α vs SPY -5.54% · entry $29.84 → $27.62
Next anchor: T+60d in 5w
Latest observation: T+34 -6.37% FF3 residual α
Entry anchored
Aug 12, 10:38 AM ET
via 1-min bar
T+1d
+0.90%
call +0.90% · α +0.21%
$30.11
settled 7w ago
T+5d
-1.78%
call -1.78% · α -1.33%
$29.31
settled 6w ago
T+20d
-7.44%
call -7.44% · α -5.54%
$27.62
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Smith & Nephew filed a 6-K reporting the vesting of 2023 Performance Share Awards under the Global Share Plan 2020 for PDMR Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations. On August 12, 2026, 23,202 ordinary shares vested at £11.096264 per share, of which 9,163 were sold to cover tax liabilities and 14,039 were retained. This is a routine administrative disclosure of equity compensation vesting with no material new information about the company's financial or operational performance.

Key Facts

  • Rohit Kashyap (PDMR) had 23,202 ordinary shares vest on August 12, 2026 under the Smith & Nephew Global Share Plan 2020.
  • Of the vested shares, 9,163 were sold to cover tax liabilities and 14,039 were retained.
  • Vesting price was £11.096264 per share on the London Stock Exchange.
  • The remaining shares under the 2023 Performance Share Award have lapsed.
  • Filing is a routine notification under UK Market Abuse Regulation with no financial or operational updates.

Financial Impact

No material financial impact — routine equity compensation vesting with tax-motivated share sales.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-007504
Document: 0001654954-26-007504-index-headers.html0001654954-26-007504
Document: 0001654954-26-007504-index.html0001654954-26-007504
Document: 0001654954-26-007504.txt0001654954-26-007504
30 reports for SNN
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +8.02%Jun 30, 2026
Filters
Rows
Reports for SNN — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 4/10
$27.50 $27.56▲ +0.22%▲ +0.44%$26.42 (−3.93%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$27.80 $28.06▲ +0.94%▲ +1.27%$26.42 (−4.96%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 4/10
$27.87 $28.01▲ +0.50%▲ +1.62%$26.42 (−5.20%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.97 $27.80▼ −4.04%▼ −4.12%$26.42 (−8.80%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access